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Originally submitted October 29, 2010; accepted for publication January 4, 2011Background. Near-infrared (NIR) fluorescence im-
aging using indocyanine green (ICG) is a promising
technique to obtain real-time assessment of the extent
and number of colorectal liver metastases during sur-
gery. The current study aims to optimize dosage and
timing of ICG administration.
Materials and Methods. Liver tumors were induced
in 18 male WAG/Rij rats by subcapsular inoculation of
CC531 rat colorectal cancer cells into three distinct
liver lobes. Rats were divided in two groups: imaging
after24and48hor72and96hafter intravenousICGad-
ministration. In each timegroup, ratswere allocated to
three dose groups: 0.04, 0.08, or 0.16mg ICG. Intraoper-
ative imaging and ex vivo measurements were per-
formed using the Mini-FLARE imaging system and
confirmed by fluorescence microscopy. Fluorescence
intensity was quantified using the Mini-FLARE soft-
wareand thedifferencebetween tumorsignal and liver
signal (tumor-to-liver ratio; TLR) was calculated.
Results. In all 18 rats, all colorectal liver metastases
(n[ 34), some as small as 1.2 mm, were identified using
ICG and the Mini-FLARE imaging system. Average
tumor-to-liver ratio (TLR) over all groups was 3.0 6
1.2. TLRwas significantly higher in the 72 h time group
compared with other time points. ICG dose did not sig-
nificantly influence TLR, but a trend was found favor-
ing the 0.08 mg dose group. Fluorescence microscopy
demonstrated a clear fluorescent rim around the
tumor.1 To whom correspondence and reprint requests should be ad-
dressed at Department of Surgery, LeidenUniversityMedical Center,
Albinusdreef 2, 2300 RC Leiden, The Netherlands. E-mail: a.l.vahr
meijer@lumc.nl.
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Open access under the Elsevier OA license.Conclusions. This study demonstrates that colorec-
tal cancer liver metastases can be clearly identified
during surgery using ICG and the Mini-FLARE imag-
ing system, with optimal timing of 72 h post-injection
and an optimal dose of 0.08 mg (0.25 mg/kg) ICG. NIR
fluorescence imaging has the potential to improve in-
traoperative detection of micrometastases and, thus,
the completeness of resection.
 2012 Elsevier Inc.
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INTRODUCTION
With a worldwide annual incidence of approximately
1 million cases and an annual mortality of over 500,000
cases, colorectal cancer is the second cause of cancer
death worldwide [1]. The survival of patients with colo-
rectal carcinoma is mostly determined by the occur-
rence of distance metastases. Approximately 30% of
patients with CRC eventually develop liver metastases
[2, 3].Whenmetastases are confined to the liver and are
resectable, surgical resection can offer a 5-y survival
rate of 35% to 40% [3, 4]. Despite improved surgical
techniques, preoperative imaging modalities, and im-
proved chemotherapy regimens, intrahepatic recur-
rence rates vary from 11% to 26% [5–8]. This is
possibly due to an inadequate assessment of the extent
of disease before and during liver surgery. Currently,
the most frequently used imaging modalities to make
this assessment are computed tomography (CT) and in-
traoperative ultrasonography (IOUS). However, even
Open access under the Elsevier OA license.
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liver metastases cannot be identified [9–11]. In particu-
lar, the detection of small (<5mm) livermetastases and
superficially located liver metastases appears to be dif-
ficult [11]. New imaging modalities are necessary to fa-
cilitate a more complete assessment of the extent of
disease.
Near-infrared (NIR) fluorescence imaging is a prom-
ising technique to intraoperatively assess the extent of
colorectal liver metastases. Recently, Ishizawa and col-
leagues [12] have shown that primary hepatocellular
carcinoma and colorectal liver metastases could be
identified using NIR fluorescence imaging and the
NIR fluorescent agent indocyanine green (ICG). Colo-
rectal liver metastases could be identified by a fluores-
cent rim around the metastases. They hypothesized
that this distinct fluorescent pattern is probably based
on biliary excretion disorders in the surrounding
normal liver tissue that is compressed by expanding
pressure of the tumor. In their study of 49 patients,
a fixed dose of 0.5 mg/kg ICG was administered preop-
eratively as part of a routine ICG clearance test, which
is commonly used in Asia to plan the safe extent of hep-
atectomy. The interval between administration of ICG
and surgery varied between 1 to 7 d. Consequently,
the optimal dose of ICG and time of administration be-
fore surgery remain unclear.
The goal of our study was to determine the optimal
ICG dose and administration time before surgery, using
a syngeneic rat model of colorectal cancer metastases in
conjunction with the Mini-FLARE image-guided sur-
gery system.MATERIALS AND METHODS
Animal Model
The colorectal cancer rat CC531 cell line was used for this study.
The cell line and the induction of livermetastases have been described
previously [13]. In short, cells were cultured in RPMI 1640 supple-
mented with 2 mM L-glutamine (Gibco, Invitrogen Ltd, Carlsbad,
CA), 10% heat-inactivated fetal calf serum, 100 U/mL penicillin,
and 0.1mg/mL streptomycin sulfate. In order to induce liver metasta-
ses, CC531-syngeneicmaleWAG/Rij rats (Harlan,Horst, TheNether-
lands) weighing approximately 300–350 g underwent median
laparotomy and the liver was mobilized and exposed. Subsequently,
125,000 CC531 cells (in 50 mL PBS) were subcapsularly inoculated
into the left and right main liver lobes and the right accessory liver
lobe [13]. Four weeks after inoculation, metastases ranging from 1.2
to 13.4 mm in size had originated in the liver.
The weight of the animals was followed throughout the experiment
to monitor their general health state. Throughout tumor inoculation,
injection of ICG and imaging, the animals were anesthetized with 5%
isoflurane for induction and 2% isoflurane for maintenance in oxygen
with a flow of 0.8 L/min. During anesthesia, the respiration rate was
constantly monitored. For postoperative analgesia, the analgesic bu-
prenorphine (0.1 mg/kg) was used. The Animal Welfare Committee
of the Leiden University Medical Center approved the experiments.
All animals were housed in the animal facility of the LeidenUniversity Medical Center. Pellet food and fresh tap water were pro-
vided ad libitum.
NIR Fluorescent Contrast Agent
The clinically available NIR fluorescent contrast agent ICG (Pul-
sion Medical Systems, Munich, Germany) was used. Three ICG dose
groups were tested: 0.04, 0.08, and 0.16 mg. Before injection, ICG
powder was resuspended in 200 mL sterile water.
Intraoperative NIR Fluorescence Imaging System
Imaging of liver metastases was performed using the Mini-FLARE
imaging system [14], which is a miniaturized version of the FLARE
imaging system [15]. Briefly, the system consists of two wavelength-
isolated light sources: a ‘‘white’’ light source, generating 26,600 l 3
of 400–650 nm light and a ‘‘near infrared’’ light source, generating
7.7 mW/cm2 of 760 nm light. Color video and NIR fluorescence images
are simultaneously acquired and displayed in real-time using custom
optics and software that separate the color video andNIRfluorescence
images. A pseudo-colored (lime green)merged image of the color video
and NIR fluorescence images is also displayed. The imaging head is
attached to a flexible gooseneck arm, which permits positioning of
the imaging head virtually anywhere over the surgical field, and at
extreme angles.
Experimental Design
In a time-dependent and dose-dependent experiment, NIR fluores-
cence imaging was performed in 18 tumor-bearing rats. To minimize
surgery-related trauma and distress, rats were divided in two groups:
imaging after 24 and 48 h, and imaging after 72 and 96 h of ICG ad-
ministration. In each time group, rats were allocated to three dose
groups of 0.04, 0.08, or 0.16 mg ICG, which was administered intrave-
nously via the penile vein. Each dose group contained three rats. ICG
dose levels were chosen based on clinically relevant doses using hu-
man body weight and correspond to doses of 10, 20, and 40 mg of
ICG. The imaging time-points were chosen based on Ishizawa et al.
[12] who reported NIR fluorescence imaging is preferably performed
at least 24 h after ICG administration. Furthermore, for clinical
translation, these time-points must be logistically acceptable to use
in a clinical setting. For intraoperative imaging, the liver and other
intra-abdominal organs were exposed after median laparotomy. After
the first intraoperative imaging session (24 or 72 h after ICG admin-
istration), the abdomen was closed in two layers and the animal was
imaged again 24 h later. At all time-points, tumor fluorescence and
fluorescence of abdominal organs were measured.
Data Analysis
NIR fluorescence data generated with the Mini-FLARE system
were analyzed using the Mini-FLARE software package. Regions-
of-interest were drawn on the outline of the tumor, liver, kidney,
spleen, stomach, small bowel, colon, and bladder as traced manually
by visual interpretation on the white light image. Subsequently, fluo-
rescence intensity was automatically calculated and exported to sta-
tistical analysis software.
Fluorescence Microscopy
After intraoperative imaging experiments at 48 or 96 h, the liver
was excised completely for ex vivo fluorescencemeasurements. Subse-
quently, liver tumors were sliced in two to examine internal fluores-
cent patterns using the Mini-FLARE system. Excised tumor slices
were snap-frozen on dry ice and stored at –80C or were fixed in
10% buffered formalin overnight, washed in 70% ethanol, and subse-
quently embedded in paraffin. Frozen tissue sections were measured
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burn, MA) mounted on a Leica DM IRE2 inverted microscope (Leica,
Wetzlar, Germany), and subsequently stained with hematoxylin and
eosin. White light images where created using the same microscope,
and subsequently merged with fluorescence images.Statistical Analysis
Statistical analysis and generation of graphs were performed using
GraphPad Prism Software (ver. 5.01; La Jolla, CA) and SPSS (ver.
17.0; SPSS Inc., Chicago, IL). Fluorescence intensity and tumor size
were reported asmean and standard deviation. To test differences be-
tween dose groups and time groups, repeated measures ANOVA was
used with rat as random factor and dose, time, and dose by time inter-
action as fixed effects. When the dose by time interaction was not sig-
nificant, it was subsequently removed from the model. Comparisons
between doses and between time points were performed using least
square difference (LSD) adjustment for multiple testing. Statistical
tests were two-tailed and P < 0.05 was considered significant.RESULTS
Intraoperative Detection of Colorectal Liver Metastases
In 18 rats, syngeneic colorectal liver metastases were
induced using the colorectal cancer rat cell line CC531.
The mean number of metastases per rat was 1.8 6 0.8
(range 1–3). The mean size of the liver metastases
was 5.2 6 0.3 mm (range 1.2–13.4 mm). In all 18 rats,
all colorectal liver metastases (n ¼ 34) were identified
using ICG and the Mini-FLARE imaging system
(Fig. 1).Dose of ICG and Time of Intraoperative Imaging
To determine the influence of ICG dosage and time of
imaging, rats were allocated to three dose groups and
imaged at four time points and tumor-to-liver ratios
(TLRs) were calculated. At all time-points (24, 48, 72,
and 96 h) and in all dose groups (0.04, 0.08, and 0.16
mg), fluorescence intensity of liver metastases was
significantly higher than the fluorescent intensity of
normal liver tissue (P < 0.001). Average TLR over allFIG. 1. Intraoperative detection of colorectal liver metastases using
image (middle) and a pseudo-colored greenmerge (right) of two CC531 co
cence in a male rat 72 h after injection of 0.08 mg indocyanine green. (Cgroups was 3.0 6 1.2. The highest average TLR (4.3 6
1.8) was reached in the 0.08 mg dose group and 72 h
after intravenous administration (Fig. 2C).
Repeated measures ANOVA was used to test for dif-
ferences in TLR between dose and time groups. There
was a significant effect of time (P < 0.001), but the ef-
fects of dose (P ¼ 0.12) and dose by time interaction
(P¼ 0.91) were not significant. Dose by time interaction
was therefore removed from the model. Consequently,
the model included rat as random factor and dose and
time as fixed effects. This model showed that the TLR
was significantly higher in the 72 h time group com-
pared to the 24 h (P < 0.001), 48 h (P ¼ 0.001), and 96
h (P ¼ 0.004) time groups (Fig. 2D). Also, the TLR
was significantly higher in the 96 h time group com-
pared to the 24 h group (P ¼ 0.049). ICG dose did not
significantly influence TLRs, but a trend was found
favoring the 0.08 mg dose group (0.08 versus 0.04,
P ¼ 0.06; 0.08 versus 0.16, P ¼ 0.09).Biodistribution of Indocyanine Green
Fluorescent intensity of the metastases, liver, kid-
ney, stomach, spleen, small bowel, colon, and bladder
was measured at all time points and in all dose groups
(data not shown).
Repeated measures ANOVA was used to test for dif-
ferences in fluorescent intensity of the liver (Fig. 2A)
and liver metastases (Fig. 2B) between dose and time
groups. Dose by time interaction did not significantly
effect liver signal (P ¼ 0.1) and metastases signal (P ¼
0.125) and was, therefore, removed from the model.
There was a significant effect of time on both liver sig-
nal (P < 0.001) and liver metastases signal (P <
0.001). No significant effect of dose was found on liver
signal (P ¼ 0.061) and metastases signal (P ¼ 0.152).
This model showed that liver signal andmetastases sig-
nal were both significantly higher in the 24 h group
compared with all other time-points (P < 0.001).NIR fluorescence: Shown are a color image (left), a NIR fluorescence
lorectal liver metastases intraoperatively detected using NIR fluores-
olor version of figure is available online.)
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FIG. 2. Dose of ICG and timing of intraoperative imaging: (A) Fluorescent intensity of the liver in 18 rats injected with 0.04, 0.08, or 0.16
after 24, 48, 72, and 96 h. (B) Fluorescent intensity of all liver tumors (n¼ 34) in 18 rats injected with 0.04, 0.08, or 0.16mg ICG after 24, 48, 72,
and 96 h. (C) Average tumor-to-liver ratios and standard deviations are plotted for all liver metastases (n ¼ 34) in 18 rats injected with 0.04,
0.08, or 0.16mg ICG after 24, 48, 72, and 96 h. (D). Estimatedmarginalmeans of tumor-to-liver ratio for rats injectedwith 0.04, 0.08, or 0.16mg
ICG after 24, 48, 72, and 96 h using the repeated measures ANOVA and least square difference (LSD) adjustment for multiple testing. This
model showed that the tumor-to-liver ratio was significantly higher in the 72 h time group compared to the 24 h (P < 0.001), 48 h (P ¼
0.001), and 96 h (P ¼ 0.004) time groups. ICG dose did not significantly influence tumor-to-liver ratios, but a trend was found favoring the
0.08 mg dose group (0.08 versus 0.04, P ¼ 0.06; 0.08 versus 0.16, P ¼ 0.09). (Color version of figure is available online.)
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stomach, colon, and the small bowel, was lower or equal
to the liver signal. Fluorescence intensity of the stom-
ach, colon, and small bowel was significantly higher
compared with other organs and had a maximum at
48 and 72 h.Microscopic Distribution of ICG in Liver Metastases
To determine the precise location of ICG in the vicin-
ity of the tumor, sliced liver metastases were examined
for internal fluorescent patterns using theMini-FLARE
system. In all liver metastases, a clear fluorescent rim
around the tumor was found. Frozen tissue sections
were examined using the Nuance multispectral imager
(CRi, Woburn, MA) mounted on a Leica DM IRE2 in-
verted microscope (Leica, Wetzlar, Germany). A clear
fluorescent rim was found in stromal tissue in the tran-
sition area between tumor and normal liver tissue in all
liver metastases. In this area, multiple cell types that
are involved in tissue inflammation (e.g., granulocytes,
lymphocytes) were found (Fig 3).DISCUSSION
In the present study, significant differences in TLR
were shown between four different time points after
ICG administration, with an optimal time of imaging
of 72 h after ICG administration. No significant effects
were found with regard to dose level; however, a trend
was shown favoring 0.08 mg. Moreover, all liver metas-
tases, even as small as 1.2 mm, could be clearly identi-
fied during liver surgery using clinically available ICG
and the Mini-FLARE system in this syngeneic rat
model.
Highest TLRs were reached 72 h after ICG adminis-
tration. Fluorescence intensity of the liver and the liver
metastases were also examined separately. Fluorescent
intensity of the liver decreased strongly after 24 h and
was not dose-dependent. Fluorescent intensity of the
liver metastases also decreased strongly at 48 h, but
a small, nonsignificant peak was found at 72 h. This
small peak can be explained by the re-uptake of ICG
in the small bowel as part of the enterohepatic circula-
tion and subsequent passage through the bowel tract,
hence the highest TLR at 72 h.
FIG. 3. Fluorescent microscopy of a colorectal liver metastasis: Shown are a hematoxylin and eosin staining (top left), a pseudo-colored
green NIR fluorescence image (top middle), and pseudo-colored green merge (top right) of a 20 mm frozen tissue section of a colorectal liver me-
tastasis. Furthermore, a phase image (bottom left), a pseudo-colored red NIR fluorescence image (bottom middle), and a pseudo-colored red
merge (bottom right) of a 20 mm frozen tissue section of a colorectal liver metastasis is shown. The fluorescent rim in stromal tissue in the tran-
sition area between tumor and normal liver tissue can be clearly identified. (Color version of figure is available online.)
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the 0.08 mg ICG group. Extrapolating to human body
weight, this dose corresponds to a dose of 20 mg ICG,
which is frequently used in a clinical setting. To opti-
mize this technique in clinical practice, a dose-finding
study is imperative. As ICG is already clinically avail-
able and FDA-approved, a straightforward translation
of our results to the clinic can be made.
It is known that a substantial part of liver metasta-
ses,mainly the small (<5mm) and superficially located,
cannot be identified using conventional imagingmodal-
ities such as CT or IOUS. Size of metastases in the pres-
ent study varied from 1.2 to 13.4mm of which 50%were
smaller than 5 mm. This emphasizes that ICG fluores-
cence in liver surgery might be of great value in detect-
ing small colorectal liver metastases. As the currently
used preclinical animal model only generated colorectal
liver metastases, future clinical studies will have to de-
termine the ability of this technique to discriminate be-
tween malignant and benign lesions of the liver.
Since maximum penetration depth of NIR fluores-
cence is currently up to 1 cm, identification of non-
superficially situated liver metastases will be more
challenging. Therefore, intraoperative ICG fluores-
cence must be regarded as a complement on currently
used conventional imaging modalities such as IOUSand CT. Improvements in imaging systems, NIR fluo-
rescence contrast agents, and software and reduction
in background fluorescence may facilitate NIR fluores-
cence imaging of deeper located metastases.
The currently used technique to detect liver metasta-
ses using NIR fluorescence and ICG is based on the
clearance capacity of the liver. It has been described
that in patients with a cirrhotic liver, or in patients pre-
treated with chemotherapy, the liver function and
clearing capacity can be reduced. A reduced liver func-
tion could also affect the clearance of ICG, which can re-
sult in a higher background signal and, therefore, lower
contrast. However, it has been shown that even cir-
rhotic livers have an extensive clearance capacity
[16]. This implies that the currently used technique
can probably be used in subjects with a reduced liver
function, although, in these patients, the optimal time
interval between ICG administration and imaging
could be longer. Future clinical studies have to elabo-
rate on this topic.
A recent development in liver surgery is the introduc-
tion of laparoscopic surgery. NIR fluorescence can be of
great value, also in laparoscopic surgery, since palpa-
tion of the liver is not possible and the surgeon can
only rely on visual inspection and preoperative imag-
ing. To anticipate this potential new application,
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presently being developed and tested [17, 18].
In summary, this study demonstrates clear identifi-
cation of colorectal liver metastases during surgery us-
ing the clinically available NIR fluorescent agent ICG
and the Mini-FLARE system. Imaging 72 h after ad-
ministration of 0.08 mg ICG provided the highest
TLRs. In particular, the ability to detect small (<5
mm) and superficially located metastases can be of
great value during liver surgery. When the current in-
traoperative identification of colorectal liver metasta-
ses can be improved using this technique, the
resection can potentially be performedmore accurately,
and preoperatively missed metastases can be involved
in surgical decision making.
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